Could TGI predict risk of Retinal Vein Occlusion in at-risk individuals with a simple calculation?
TyG index could help as a reliable guide to identify individuals with Retinal Vein Occlusion with high risk and initiate early intervention suggests a study published in the Turkish Journal of Ophthalmology.
The triglyceride-glucose (TyG) index is a sign of atherosclerosis in cardiovascular diseases. The TyG index is thought to have clinical significance for the assessment of vascular damage. In this study, we aimed to demonstrate the connection between the TyG index and retinal vein occlusion (RVO). This case-control observational study involved 492 participants aged 40-90, admitted to the ophthalmology outpatient clinic of our hospital. TyG index was calculated using the formula: ln(fasting TG [mg/dL] × fasting plasma glucose [mg/dL]/2). Results: The RVO group included 387 patients (181 women and 206 men) and the control group included 115 patients (61 women and 54 men). The average patient age was 62.9±11.1 years in the RVO group and 56.7±8.7 years in the control group. The TyG index was higher in the RVO group (8.9±0.7) than in the control group (8.8±0.6). This difference was statistically significant (p=0.04). The correlation was statistically significant when evaluated according to age and sex by multivariate logistic regression analysis (odds ratio: 1.45, confidence interval: 1.03- 2.02, p=0.03). The TyG index is a novel atherogenicity index that is derived from routine blood tests and can be used to determine the risk of RVO in at-risk individuals with a simple calculation. Therefore, the TyG index could help as a reliable guide to identify individuals at RVO with high risk and initiate early intervention.
Reference:
Katipoğlu, Zeynep, and Meydan Turan. "Could Triglyceride-Glucose Index, a Predictor of Atherosclerosis, Be Associated With Retinal Vein Occlusion?" Turkish Journal of Ophthalmology, vol. 54, no. 3, 2024, pp. 149-152.
Keywords:
TGI, Predic, Atherosclerosis, Associated, Retinal Vein Occlusion, Turkish Journal of Ophthalmology, Katipoğlu, Zeynep, and Meydan Turan
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.